NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq:NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2022 after market close on Thursday, March 2, 2023. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Related news for (NPCE)
- NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
- NeuroPace Provides Update on Tariff Status
- NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
- NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
- NeuroPace Announces Refocusing of Product Portfolio